hydroxychloroquine has been researched along with Failure to Thrive in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Failure to Thrive: A condition of substandard growth or diminished capacity to maintain normal function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabach, I | 1 |
| Poli, F | 1 |
| Zennaro, F | 1 |
| Germani, C | 1 |
| Ventura, A | 1 |
| Barbi, E | 1 |
1 other study available for hydroxychloroquine and Failure to Thrive
| Article | Year |
|---|---|
Is treatment with hydroxychloroquine effective in surfactant protein C deficiency?
Topics: Disease Progression; Diseases in Twins; Dyspnea; Failure to Thrive; Humans; Hydroxychloroquine; Infa | 2013 |